Closed-system manufacturing of therapeutic NK cells using automated cell enrichment and concentration processes enables scalable, robust and cost-effective solutionsNina Kok, Monica Raimo, Zoë Dekkers et al.|Frontiers in Bioengineering and Biotechnology|2025Cited by 7
The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variantThomas Bos, Marianne Bootsma, Laurens P. Bosman et al.|Netherlands Heart Journal|2023Cited by 3
Arrhythmogenic cardiomyopathy phenotype associated with the pathogenic founder variant c.1211dup in PKP2Thomas Bos, Daniela Q.C.M. Barge‐Schaapveld, Sebastiaan R.D. Piers et al.|European Heart Journal|2023Cited by 0